DOMINO SPONSORS MAJOR SUMMIT ON ROLE OF CODING, RFID AND EPC IN SECURE HEALTHCARE SUPPLY CHAINS
DOMINO SPONSORS MAJOR SUMMIT ON ROLE OF CODING, RFID AND EPC IN SECURE HEALTHCARE SUPPLY CHAINS
The hottest topic in healthcare supply chain management - how best to exploit track-and-trace technologies such as coding, RFID and EPC to ensure security and protect patients - will come under the spotlight at a major conference in Dublin on Thursday, 30th November 2006 at IBM's RFID Centre of Excellence.
Sponsored by Domino's Integrated Solutions Group, "Securing the European Healthcare Supply Chain - Where does RFID/EPC fit?" is presented by the GS1 Europe European Healthcare Initiative in conjunction with EPCglobal's Healthcare & Life Sciences business action group.
The event will feature a line-up of high-calibre authorities drawn from RFID/EPC communities on both sides of the Atlantic, including John M. Gray, president and CEO of the Healthcare Distribution Management Association (HDMA), the US's leading representative body for the healthcare distribution industry. Mr Gray will provide an update on recent developments in the United States, where the Federal Drug Administration continues to drive progress in key areas such as 'electronic pedigrees' for pharmaceuticals to combat the threat of counterfeit products.
A complementary overview of what is happening in Europe will be provided by Hugo Bonar, manager of the enforcement unit of the Irish Medicines Board. Bob Celeste of EPCglobal will report on the latest developments within EPCglobal's Healthcare & Life Sciences action group. Dr Barry White from Ireland's National Centre for Hereditary Coagulation Disorders in Ireland will present a vivid example of the potential of track and trace technologies to secure supply chains.
For further information, contact John Jenkins, GS1 Europe Healthcare Initiative on +44 (0) 118 903 4073 or by email john.Jenkins@jjassociates.com To enroll go to www.gs1health.net (see EPC in healthcare page).
For further information on Domino, please visit www.domino-printing.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.